754 related articles for article (PubMed ID: 30694095)
1. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.
Burnouf T; Agrahari V; Agrahari V
Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
4. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
[TBL] [Abstract][Full Text] [Related]
5. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
Ingato D; Lee JU; Sim SJ; Kwon YJ
J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
[TBL] [Abstract][Full Text] [Related]
6. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine.
Fais S; O'Driscoll L; Borras FE; Buzas E; Camussi G; Cappello F; Carvalho J; Cordeiro da Silva A; Del Portillo H; El Andaloussi S; Ficko Trček T; Furlan R; Hendrix A; Gursel I; Kralj-Iglic V; Kaeffer B; Kosanovic M; Lekka ME; Lipps G; Logozzi M; Marcilla A; Sammar M; Llorente A; Nazarenko I; Oliveira C; Pocsfalvi G; Rajendran L; Raposo G; Rohde E; Siljander P; van Niel G; Vasconcelos MH; Yáñez-Mó M; Yliperttula ML; Zarovni N; Zavec AB; Giebel B
ACS Nano; 2016 Apr; 10(4):3886-99. PubMed ID: 26978483
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicle-based drug delivery systems for cancer treatment.
Walker S; Busatto S; Pham A; Tian M; Suh A; Carson K; Quintero A; Lafrence M; Malik H; Santana MX; Wolfram J
Theranostics; 2019; 9(26):8001-8017. PubMed ID: 31754377
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicles as Natural Nanosized Delivery Systems for Small-Molecule Drugs and Genetic Material: Steps towards the Future Nanomedicines.
Kotmakçı M; Bozok Çetintaş V
J Pharm Pharm Sci; 2015; 18(3):396-413. PubMed ID: 26517135
[TBL] [Abstract][Full Text] [Related]
10. Emerging Significance and Therapeutic Potential of Extracellular vesicles.
Luo R; Liu M; Tan T; Yang Q; Wang Y; Men L; Zhao L; Zhang H; Wang S; Xie T; Tian Q
Int J Biol Sci; 2021; 17(10):2476-2486. PubMed ID: 34326688
[TBL] [Abstract][Full Text] [Related]
11. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
12. Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.
Sutaria DS; Badawi M; Phelps MA; Schmittgen TD
Pharm Res; 2017 May; 34(5):1053-1066. PubMed ID: 28315083
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity.
Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB
J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles in cancer nanomedicine.
Tarasov VV; Svistunov AA; Chubarev VN; Dostdar SA; Sokolov AV; Brzecka A; Sukocheva O; Neganova ME; Klochkov SG; Somasundaram SG; Kirkland CE; Aliev G
Semin Cancer Biol; 2021 Feb; 69():212-225. PubMed ID: 31421263
[TBL] [Abstract][Full Text] [Related]
15. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
Meng W; He C; Hao Y; Wang L; Li L; Zhu G
Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
[TBL] [Abstract][Full Text] [Related]
16. Targeting Inflammatory Vasculature by Extracellular Vesicles.
Wang S; Dong X; Gao J; Wang Z
AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics.
Liu C; Gao H; Lv P; Liu J; Liu G
Hum Vaccin Immunother; 2017 Nov; 13(11):2678-2687. PubMed ID: 28949786
[TBL] [Abstract][Full Text] [Related]
18. Chromatography and its hyphenation to mass spectrometry for extracellular vesicle analysis.
Pocsfalvi G; Stanly C; Fiume I; Vékey K
J Chromatogr A; 2016 Mar; 1439():26-41. PubMed ID: 26830636
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles in the Development of Cancer Therapeutics.
Sun H; Burrola S; Wu J; Ding WQ
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
Raimondo S; Giavaresi G; Lorico A; Alessandro R
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
